DCF Advisers »

Zenas Biopharma shares owned by DCF Advisers

Quarter-by-quarter ownership of Zenas Biopharma (ZBIO) shares owned by DCF Advisers from 13F filings

Historical chart of DCF Advisers investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by DCF Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by DCF Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $715k 28k 25.38

More positions owned by DCF Advisers

Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Micron Technology (MU)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Advanced Micro Devices (AMD)
Amazon (AMZN)
Argenx Se Sponsored Adr (ARGX)
Corvus Pharmaceuticals (CRVS)
Cybin Com New (HELP)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Marvell Technology (MRVL)
Ishares Gold Tr Ishares New (IAU)
Bank of America Corporation (BAC)
Microsoft Corporation (MSFT)
Regeneron Pharmaceuticals (REGN)

View all positions for DCF Advisers

Top funds holding Zenas Biopharma

FMR
Sr One Capital Management
NEA Management Company
Enavate Sciences GP
Federated Investors
BlackRock
Capital Research and Management Company - Division 3
Polar Capital Holdings
Royalty Pharma Sub-Manager
Fairmount Funds Management
NVP Associates
Wellington Management Company
State Street Corporation
Vanguard Capital Management
Bank of America Corporation

View all funds holding Zenas Biopharma